课题基金 / 基金详情

Ensuring a Successful Transition from Pap to HPV DNA Testing in Primary Cervical Cancer Screening: Exploring and Listening to Canadian Women's Needs is Critical for Effective Public Policy Change

Ensuring a Successful Transition from Pap to HPV DNA Testing in Primary Cervical Cancer Screening: Exploring and Listening to Canadian Women's Needs is Critical for Effective Public Policy Change
确保初级宫颈癌筛查中从巴氏涂片检测成功过渡到 HPV DNA 检测：探索和倾听加拿大妇女的需求对于有效的公共政策变革至关重要
批准号：
402022
负责人：
Rosberger Zeev
金额：
$18.39万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-03-01 至 2021-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=402022&lang=en
关键词：
Canada Wide Population Based Survey Cervical Cancer Prevention Human Papillomavirus Kabp (Knowledge, Attitudes, Beliefs, Practices) Pap And Hpv Screening

项目摘要

项目成果

Rosberger Zeev的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In their lifetime, 75% of sexually active women will be infected with the Human Papillomavirus (HPV) which is the proven cause of cervical cancer. In Canada, the Pap test (smear) is used to monitor changes in the cervix, usually every 2-3 years. Too many
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Promoting protection of others to increase future COVID-19 booster shot vaccination intentions in younger adult Canadians: Evaluating the efficacy of a short video-based intervention
Parents, Sons and the HPV Vaccine: What Factors Influence Decision-Making Over Time?
Parents, Daughters, and the HPV Vaccine: Factors Affecting Parental Decision-Making in a Universal Immunization Program
海外基金